Dr. Reddy's Laboratories Limited: all 249 studies

Page 1 of 3. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate Pharmacokinetics of DRL_AB in Healthy Male ParticipantsNot yet recruitingNCT07744828Phase 1
• AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)Not yet recruitingNCT07640737Phase 2
• Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced LymphomaRecruitingNCT06755450Phase 1
• A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting ConditionsNot yet recruitingNCT06193187Phase 1
• Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous RouteRecruitingNCT06126042Phase 1
• A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)RecruitingNCT05984147Phase 1
• A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)RecruitingNCT05865002Phase 1
• Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 PatientsTerminatedNCT04529499Phase 3Results posted
• A Phase III Transition Study of DRL Rituximab to Reference Medicinal ProductsCompletedNCT04268771Phase 3Results posted
• A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe PsoriasisCompletedNCT04207801Phase 2Results posted
• Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular LymphomaCompletedNCT03976102Phase 3Results posted
• A Bioavailability Study of DFD-03 Compared to Tazorac® in Patients With Moderate Acne VulgarisCompletedNCT03599193Phase 2Results posted
• Efficacy, Tolerability, Safety, and Pharmacokinetic Study of DFN-15CompletedNCT03554772Phase 2Results posted
• A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)CompletedNCT03421197Phase 2Results posted
• A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne VulgarisCompletedNCT03341910Phase 2Results posted
• A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release CapsulesCompletedNCT03340961Phase 2Results posted
• A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 WeeksCompletedNCT03292640Phase 3Results posted
• A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne VulgarisCompletedNCT03290027Phase 3Results posted
• A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment PeriodCompletedNCT03116698Phase 2/3Results posted
• A Study to Assess the Efficacy, Safety and Tolerability of DFD-04CompletedNCT02828241Phase 2Results posted
• Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and ScalpCompletedNCT02654717Phase 2Results posted
• A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque PsoriasisCompletedNCT02635204Phase 3Results posted
• Pilot Study of DFN-11 Injection in Medication Overuse HeadacheTerminatedNCT02583425Phase 2Results posted
• Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating MigraineCompletedNCT02571049Phase 2Results posted
• DFN-11 Injection in Episodic Migraine With or Without AuraCompletedNCT02569853Phase 3Results posted
• A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque PsoriasisCompletedNCT02445807Phase 3Results posted
• Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three Anti-CD20 Monoclonal Antibodies in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT02296775Phase 1/2Results posted
• DFN-02 Open Label Safety Study in Patients With Acute MigraineCompletedNCT02279082Phase 3Results posted
• A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type PsoriasisCompletedNCT02173301Phase 2Results posted
• DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT02131324Phase 2Results posted
• ACT01 in Combination With Comp01-04 in Patients With Actinic KeratosisCompletedNCT02126670Phase 2Results posted
• Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice InfestationCompletedNCT02097485Phase 2Results posted
• Dermal Safety Study to Evaluate Potential Irritation of Abametapir LotionCompletedNCT02061813Phase 1Results posted
• A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice InfestationCompletedNCT02060903Phase 3Results posted
• Safety and PK Study of Ha44 Gel Under Maximal Use Conditions for Treatment of Head Lice InfestationCompletedNCT01907490Phase 2Results posted
• Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal SurgeryCompletedNCT01888367Phase 2Results posted
• Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque PsoriasisCompletedNCT01714544Phase 4Results posted
• Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy VolunteersCompletedNCT01518699Phase 1Results posted
• DFA-02 in Patients Undergoing Colorectal SurgeryCompletedNCT01496352Phase 1/2Results posted
• A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol LevelsCompletedNCT01388816Phase 2Results posted
• An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice InfestationCompletedNCT01336647Phase 2Results posted
• Promiseb Topical Cream for Cradle CapCompletedNCT01214434Phase 4Results posted
• Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic DermatitisCompletedNCT00828412Phase 4Results posted
• A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction AdenocarcinomaTerminatedNCT07040059Phase 1/2
• A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)TerminatedNCT06761586Phase 1
• A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal CancersTerminatedNCT06760702Phase 2
• A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesTerminatedNCT05861947Phase 1
• A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and PharmacodynamicsTerminatedNCT05607199Phase 1
• First in Human, Dose Escalation, Dose Expansion Study of AUR105TerminatedNCT05605119Phase 1
• Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-Status unknownNCT05140655
• A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)CompletedNCT04855721Phase 2
• Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) InfectionStatus unknownNCT04640233Phase 2/3
• Bioequivalence Study of Guaifenesin and Pseudoephedrine Hydrochloride Extended Release Tablets 1200/120 mg Under Fasting ConditionsCompletedNCT03706300Phase 1
• Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed ConditionsCompletedNCT03702855Phase 1
• Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fasting ConditionsCompletedNCT03696329Phase 1
• Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult SubjectsCompletedNCT03282838Phase 1
• Levofloxacin as an Empirical Therapy in Patients With Complicated Urinary Tract InfectionsStatus unknownNCT03160807Phase 4
• Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy AdultsCompletedNCT03051685Phase 1
• Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteoarthrosis (Gonarthrosis)CompletedNCT02922712Phase 4
• Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated DiseasesCompletedNCT02922699Phase 4
• Amtolmetin Gaucil in Knee OsteoarthritisCompletedNCT02865161
• Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common WartsCompletedNCT02798419Phase 2
• Levofloxacin in Bacterial RhinosinussitisCompletedNCT02712502
• Non Interventional Study of Levofloxacin in Chronic ProstatitisCompletedNCT02711943
• Ketorol Gel in Gonarthrosis and Low Back PainCompletedNCT02638831Phase 4
• A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of ScabiesCompletedNCT02572986Phase 3
• Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine HeadachesCompletedNCT02472418Phase 2
• Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed ConditionsCompletedNCT02322658Phase 1
• Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting ConditionsCompletedNCT02322645Phase 1
• Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting ConditionsCompletedNCT02322632Phase 1
• Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting ConditionsCompletedNCT02322619Phase 1
• Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal CancerStatus unknownNCT02301962Phase 4
• Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting ConditionCompletedNCT02297854Phase 1
• Bioavailability Study of Sirolimus Tablets 2 mg Under Fed ConditionCompletedNCT02296762Phase 1
• Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting ConditionCompletedNCT02296749Phase 1
• Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fed ConditionCompletedNCT02296723Phase 1
• Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting ConditionCompletedNCT02295046Phase 1
• Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed ConditionCompletedNCT02292069Phase 1
• Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting ConditionCompletedNCT02291367Phase 1
• Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed ConditionCompletedNCT02291341Phase 1
• Bioequivalence Study of Doxorubicin Hydrochloride Liposome InjectionCompletedNCT02260544Phase 1
• A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy VolunteersStatus unknownNCT02205320Phase 1
• Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir LotionCompletedNCT02062073Phase 1
• Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice InfestationCompletedNCT02062060Phase 3
• A Pediatric Safety and Pharmacokinetics Study of Ha44 Gel Administered Topically for Treatment of Head Lice InfestationCompletedNCT02010333Phase 2
• Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting ConditionCompletedNCT01923558Phase 1
• Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed ConditionCompletedNCT01923259Phase 1
• Lamotrigine Extended-Release Tablets 50 mg Under Fed ConditionCompletedNCT01888757Phase 1
• Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting ConditionCompletedNCT01888731Phase 1
• Bioequivalence Study of Fexofenadine Hydrochloride Orally Disintegrated Tablets 30 mg Under Fasting ConditionCompletedNCT01888718Phase 1
• Bioequivalence Study of Isotretinoin Capsules 20 mg Under Fasting ConditionCompletedNCT01888341Phase 1
• Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fed ConditionCompletedNCT01888328Phase 1
• Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting ConditionCompletedNCT01888289Phase 1
• Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed ConditionCompletedNCT01888263Phase 1
• Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting ConditionCompletedNCT01888250Phase 1
• Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed ConditionCompletedNCT01888224Phase 1
• Bioequivalence Study for Metoprolol Succinate ER Tablets 50 mg Under Fasting ConditionCompletedNCT01694797Phase 1
• Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed ConditionCompletedNCT01691469Phase 1
• Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting ConditionCompletedNCT01691456Phase 1
• Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic ConstipationCompletedNCT01674530Phase 3

← Dr. Reddy's Laboratories Limited overview and focus areas